Navigation Links
Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
Date:3/31/2008

DURHAM, N.C., March 31 /PRNewswire/ -- Pharmaceutical Strategic Initiatives (PSI), a provider of marketing consultation and content development services to the pharmaceutical industry, has added Anne L. Sexton MD, MS to its management team as Vice President of Medical Activities.

Dr. Sexton brings 15 years of clinical and pharmaceutical experience to PSI. Dr. Sexton's broad experience includes medical affairs and medical monitoring, drug development strategy, regulatory affairs activities including FDA submissions, drug safety/pharmacovigilance and medical writing.

According to PSI President Charles Carter, PhD, "Anne brings the clinical and industry experience our customers need to develop and implement their integrated medical affairs strategies and support regulatory initiatives."

Prior to joining PSI, Dr. Sexton headed an independent consulting company serving the pharmaceutical and biotech industries.

About Pharmaceutical Strategic Initiatives

PSI was founded in 1988 by Charles Carter, PharmD, MBA and is part of Interactive Holdings. PSI provides strategic marketing consultation and content development services to the pharmaceutical industry. For more information about PSI, contact Mary Messina at 919.314.1380 or visit http://www.psillc.com.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
3. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
4. Barr Pharmaceuticals, Inc. Executive Bios
5. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
6. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
7. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
8. Surveys Find Key Changes in the Role of the Pharmaceutical CFO
9. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
10. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
11. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is ... software, The Guard®, has helped another long-time client pass their Department of Health ... satisfy the law. , Thanks to the help of the Compliancy Group's Audit ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare ... Rule that it will transition to using only Worksheet S-10 to distribute Disproportionate Share ... of three live 60-minute complimentary webinars on October 17, 2017 at 2 ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... for overcoming addiction. “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the ... extensive background in the field of addiction and homeless services, including more than ...
(Date:9/20/2017)... ... ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning to see ... Liston, a busy mother of five who used her time waiting for children to finish ... over twenty years. It was a way to give some meaning to the hours ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians ... include Brevard’s own Ross A. Clevens, MD, FACS . The founder and medical ... Plastic and Reconstructive Surgeon who trained at Yale, Harvard and the University of Michigan. ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will present ... 11, 2017, in New York . ... scheduled to present at 11:05 a.m. Eastern Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one hour ... 2017. About Hill-Rom ...
Breaking Medicine Technology: